ArticleProceedings of the National Academy of Sciences of the United States of America2020

PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition.

Jennifer M Spangle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.